This session, covering seven presentations, will give a clear and comprehensive overview of the major regulatory changes and the impact on each stakeholder group: Representatives from Notified Bodies, the MedTech Industry including SME's and, in particular, surgeons, will point out the specific challenges they will face and the resultant impact on research, medical care and economics. Share your expertise and participate in a much needed discussion: Share for better patient care!
In the healthcare industry, 3D printing is a never-before-seen breakthrough enabling a cost-effective and rapid production of individualized products. Strong market growth is expected in the coming years. The aim of this session, structured in five presentations, is to give an in-depth insight into this latest technology 3D printing of patient-specific implants. Presenting the regulator's, manufacturer's, and user's views, various aspects ranging from regulatory requirements to reimbursement issues will be debated. Furthermore, the latest stage of research and development of the cutting-edge technology 3D bio printing of tissues will be presented—what is feasible, where are the limitations?
The four break-out sessions offer the opportunity for an in-depth exchange within a smaller circle of internationally accounted experts on different MedTech-related themes. Each break-out will start with three expert presentations pointing out different aspects and perspectives on the particular topic covered followed by a moderated discussion. Each participant is invited to join one of the following break-out sessions to participate in a lively discussion! Break-out 1: MDR and MedDev: Is there a future for small and medium-sized MedTech enterprises? Break-out 2: When things go wrong: Who is liable? Break-out 3: How to measure the impact of health care on patient outcome? Break-out 4: How to involve patients in medical device development?
Increasing product licensing requirements, pricing/reimbursement regulations, and growing cost pressures calls for best practices, new tools, and intensive discussions in the field of health technology assessment and outcomes research. This session offers insights into state-of-the-art methodological approaches, possibilities and limitations of health economics and outcomes research. Moreover, it will be discussed if HTA – mainly applied to pharmaceuticals – can work effectively for assessing medical devices.
The world's ﬁrst interdisciplinary conference on musculoskeletal devices starts in
Because the future is interdisciplinary: Become a participant at the first interdisciplinary conference on musculoskeletal devices and take advantage of this unique opportunity to exchange and network with all the experts involved.
The registration fee includes:
Until September 1, 2016SAVE € 400
*Application for Surgeon/Researcher/Hospital/Non-profit/Governments/EU Officials registrations need to be confirmed by a status certification from the entity or organization or institution, stating that the applicant is working for this entity at the time of registration.
If you have any questions regarding the registration, please contact:
Because the future is interdisciplinary: Become a sponsor of the first interdisciplinary conference on musculoskeletal devices and take advantage of this unique opportunity to connect with all the experts involved in the development and use of musculoskeletal devices. The changing environment and upcoming challenges in this field require enhanced interdisciplinary collaboration and support.
Contact us and secure the best sponsoring opportunities.